CHICAGO, Feb. 8, 2016, MORN /PRNewswire/ — Morningstar, Inc. (NASDAQ: MORN), a leading provider of independent investment research, has published a summary of Morningstar Analyst Rating™ activity for 78 U.S. funds and one target-date series that occurred in January 2016. The Morningstar Analyst Rating for funds represents Morningstar’s conviction in the fund’s ability to outperform on a risk-adjusted basis over the long term. The five-tiered, qualitative Morningstar Analyst Rating scale has three positive levels, indicating Morningstar Medalists—Gold, Silver, and Bronze—inRead more
- CytoDyn Announces Productive Pre-BLA Meeting with FDA for PRO 140 Combination Therapy
- Maven to Launch Sports Network in Partnership with The Sports Xchange
- Freedom Leaf Enters $20 Billion Anti-Cholesterol Market With Acquisition of a Patent Pending Non-Prescription Formula. No FDA Approval Required. Complimentary Diversification In Health Care
- PotNetwork Holdings, Inc.’s Diamond CBD Continues Surpassing $2 Million In Sales Per Month Practically Doubling Revenues Year Over Year
- Chinese eSports Tournament Group Seeks to Add Cryptocurrency to Their Prize Pools
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More